A series of pathways, including the NF-κB, Nrf2, and TGF-β signaling pathways, are activated by major pathophysiological processes in DN such as hyperglycemia, oxidative stress, advanced glycation end products (AGEs), and angiotensin II. This evidence concerns the gene TGFB1 and Hyperglycemia.